Identification
- Summary
Elymus repens pollen is an extract from Elymus repens pollen used in allergy testing.
- Generic Name
- Elymus repens pollen
- DrugBank Accession Number
- DB10489
- Background
Elymus repens pollen is the pollen of the Elymus repens plant. Elymus repens pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- quackgrass pollen extract
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Acebutolol. Atenolol The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Atenolol. Benazepril The risk or severity of adverse effects can be increased when Benazepril is combined with Elymus repens pollen. Betaxolol The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Betaxolol. Bisoprolol The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Bisoprolol. Captopril The risk or severity of adverse effects can be increased when Captopril is combined with Elymus repens pollen. Carvedilol The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Carvedilol. Celiprolol The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Celiprolol. Cilazapril The risk or severity of adverse effects can be increased when Cilazapril is combined with Elymus repens pollen. Enalapril The risk or severity of adverse effects can be increased when Enalapril is combined with Elymus repens pollen. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Couch Quack Grass Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US 
Couch Quack Grass Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Couch Quack Grass Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Couch Quack Grass Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Couch Quack Grass Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Couch Quack Grass Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Couch Quack Grass Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Couch Quack Grass Solution 0.1 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Couch Quack Grass Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Couch Quack Grass Injection, solution 40000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US - Mixture Products
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ON2T85TA2O
- CAS number
- Not Available
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.10 g/1mL Injection, solution Subcutaneous 40000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53